AA
MTEM

ALPS Advisors’s Molecular Templates, Inc. MTEM Stock Holding History

ALPS Advisors’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,588
Closed -$462K – 999
2021
Q3 		$462K Sell
4,588
-337
-7% -$34.8K ﹤0.01% 511
2021
Q2 		$578K Sell
4,925
-1,101
-18% -$144K 0.01% 501
2021
Q1 		$1.14M Buy
6,026
+11
+0.2% +$1.93K 0.01% 383
2020
Q4 		$847K Buy
6,015
+1,771
+42% +$262K 0.01% 407
2020
Q3 		$695K Buy
4,244
+87
+2% +$15.5K 0.01% 387
2020
Q2 		$860K Buy
+4,157
New +$966K 0.01% 354
2018
Q2 		– Sell
-2,403
Closed -$288K – 977
2018
Q1 		$288K Buy
2,403
+417
+21% +$62.8K ﹤0.01% 821
2017
Q4 		$298K Buy
+1,986
New +$249K ﹤0.01% 739
2015
Q4 		– Sell
-677
Closed -$4.54K – 706
2015
Q3 		$4.54K Buy
677
+248
+58% +$176K ﹤0.01% 568
2015
Q2 		$286K Buy
429
+216
+101% +$143K ﹤0.01% 659
2015
Q1 		$143K Buy
+213
New +$140K ﹤0.01% 648

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ALPS Advisors's MTEM Position: Q4 2021 in Review

ALPS Advisors sold out of Molecular Templates, Inc. (MTEM) in Q4 2021, closing a stake of 4,588 shares — an estimated $462K sold.

ALPS Advisors first reported a position in MTEM in Q1 2015 and held it in 11 quarters. The position peaked at $1.14M in Q1 2021. 79 funds tracked by Wall St. Rank hold MTEM as of Q4 2021.

  • ALPS Advisors reported no remaining Molecular Templates, Inc. position as of Q4 2021 after selling out during the quarter.
  • ALPS Advisors sold 4,588 Molecular Templates, Inc. shares in Q4 2021, an estimated $462K.
  • ALPS Advisors first reported a position in Molecular Templates, Inc. in Q1 2015 and held it in 11 quarters.
  • ALPS Advisors's Molecular Templates, Inc. position peaked at $1.14M in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2021.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.